Skip to content
Loading…
Administered just twice a year, the drug Lenacapavir offers near-complete protection — more than 99% — against HIV. After years of research and clinical trials, the preventive treatment has been approved and is now set to be rolled out on a large scale. Mass rollout campaigns…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on France 24.